Select Year
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
MENU
Strategic Plan Questions
Funders
Federal vs. Private
Strategic Plan Multiyear Funding
Strategic Plan Objectives
Subcategories
Geography
About
Question 2: Short-term Objective E
Q2.S.E : Launch three studies that target the underlying biological mechanisms of co-occurring conditions with autism, including seizures/epilepsy, sleep disorders, wandering/elopement behavior, and familial autoimmune disorders, by 2012.
Projects Found: 22
Total Funding: $3,218,960
Display
10
20
30
Records
Autism Speaks
Single-unit recordings in neurosurgical patients with autism
$55,200
$55,200
California Institute of Technology
Autism Speaks
Salivary melatonin as a biomarker for response to sleep interventions in children with autism
$0
$0
University of Colorado Denver
Autism Speaks
The effects of disturbed sleep on sleep-dependent memory consolidation and daily function in individuals with ASD
$90,480
$90,480
Beth Israel Deaconess Medical Center
Autism Speaks
The role of mTOR inhibitors in the treatment of autistic symptoms in symptomatic infantile spasms
$0
$0
Albert Einstein College of Medicine of Yeshiva University
Autism Speaks
Characterization of the sleep phenotype in adolescents and adults with autism spectrum disorder
$150,000
$150,000
Vanderbilt University
Health Resources and Services Administration
Epileptiform discharges and its relation to cognition and behavior in children with autism spectrum disorders
$0
$0
Vanderbilt University
National Institutes of Health
Self-regulation and sleep in children at risk for autism spectrum disorders
$87,899
$87,899
University of California, Davis
National Institutes of Health
Molecular mechanisms linking early life seizures, autism and intellectual disability
$333,473
$333,473
University of Colorado Denver
National Institutes of Health
Neuroendocrine regulation of metabolism and neurocognition
$402,805
$402,805
National Institutes of Health
National Institutes of Health
Treatment of medical conditions among individuals with autism spectrum disorders
$339,591
$339,591
National Institutes of Health